全文获取类型
收费全文 | 1343篇 |
免费 | 123篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 43篇 |
妇产科学 | 23篇 |
基础医学 | 126篇 |
口腔科学 | 32篇 |
临床医学 | 161篇 |
内科学 | 169篇 |
皮肤病学 | 9篇 |
神经病学 | 75篇 |
特种医学 | 89篇 |
外科学 | 389篇 |
综合类 | 44篇 |
预防医学 | 93篇 |
眼科学 | 10篇 |
药学 | 129篇 |
中国医学 | 1篇 |
肿瘤学 | 82篇 |
出版年
2023年 | 10篇 |
2022年 | 10篇 |
2021年 | 27篇 |
2020年 | 13篇 |
2019年 | 17篇 |
2018年 | 21篇 |
2017年 | 16篇 |
2016年 | 12篇 |
2015年 | 39篇 |
2014年 | 41篇 |
2013年 | 55篇 |
2012年 | 49篇 |
2011年 | 59篇 |
2010年 | 47篇 |
2009年 | 35篇 |
2008年 | 48篇 |
2007年 | 62篇 |
2006年 | 58篇 |
2005年 | 60篇 |
2004年 | 49篇 |
2003年 | 50篇 |
2002年 | 41篇 |
2001年 | 35篇 |
2000年 | 38篇 |
1999年 | 37篇 |
1998年 | 25篇 |
1997年 | 29篇 |
1996年 | 24篇 |
1995年 | 21篇 |
1994年 | 13篇 |
1993年 | 22篇 |
1992年 | 13篇 |
1991年 | 22篇 |
1990年 | 24篇 |
1989年 | 37篇 |
1988年 | 28篇 |
1987年 | 29篇 |
1986年 | 28篇 |
1985年 | 13篇 |
1984年 | 21篇 |
1983年 | 18篇 |
1982年 | 15篇 |
1980年 | 10篇 |
1979年 | 17篇 |
1977年 | 13篇 |
1976年 | 14篇 |
1974年 | 11篇 |
1972年 | 13篇 |
1968年 | 10篇 |
1966年 | 10篇 |
排序方式: 共有1488条查询结果,搜索用时 0 毫秒
991.
Z. Bentatou M. Finas P. Habert F. Kober M. Guye S. Bricq A. Lalande J. Frandon JN. Dacher B. Dubourg G. Habib J. Caudron S. Normant S. Rapacchi M. Bernard A. Jacquier 《Diagnostic and interventional imaging》2018,99(11):689-698
Purpose
The purpose of this study was to quantify the distribution of trabeculated (T) and compact (C) left ventricular (LV) myocardium masses in a healthy Caucasian population against age, gender and LV parameters, and to provide normal values for T, C and T/C.Materials and methods
One hundred and forty healthy subjects were prospectively recruited and underwent cardiac MRI at 1.5 T with a stack of short-axis cine sequences covering the entire LV. End-diastolic volume (EDV), C and T masses were quantified using a semi-automatic method. Ejection fraction (EF) and T/C ratio were computed.Results
We included 70 men and 70 women with a mean age of 44 ± 14 (SD) years (range: 20–69 years). The mean EF was 63.7 ± 6.3 (SD) % (range: 50.7–82.0%), the mean EDV was 75.9 ± 16.2 (SD) mL/m2 (range: 36.4–112.2 mL/m2), the mean C mass was 53.9 ± 11.2 (SD) g/m2 (range: 26.5–93.4 g/m2) and the mean T mass was 4.9 ± 2.4 (SD) g/m2 (range: 1.1–11.4 g/m2). The T/C ratio was 9.2 ± 4.5% (range: 2.0–29.4%). Multivariate ANOVA test showed that the compact mass was influenced by EDV (P < 0.0001), EF (P = 0.001) and gender (P < 0.0001), and the trabeculated mass depended on EDV (P < 0.0001), gender (P = 0.002) and age (P < 0.0001), while the T/C ratio was only influenced by age (P = 0.0003). Spearman test showed a correlation between EDV and C (r = 0.60; P < 0.0001), T (r = 0.46; P < 0.0001) and T/C ratio (r = 0.26; P = 0.0023). T and T/C ratio correlated with EF (r = ?0.18, P = 0.0373; r = ?0.18, P = 0.0321, respectively).Conclusion
While the compact and trabeculated myocardium masses appear to relate separately to the cardiac function, age and gender, their ratio T/C appears to only decrease with age. Furthermore, we propose here normal values for T, C and T/C in a cohort of healthy Caucasians subjects. 相似文献992.
Hass CJ Gregor RJ Waddell DE Oliver A Smith DW Fleming RP Wolf SL 《Archives of physical medicine and rehabilitation》2004,85(10):1593-1598
OBJECTIVE: To determine if a program of intense Tai Chi exercise that has been shown to reduce the risk of falling in older adults improves postural control by altering the center of pressure (COP) trajectory during gait initiation. DESIGN: Before-after trial. SETTING: Biomechanics research laboratory. PARTICIPANTS: Twenty-eight older adults transitioning to frailty who participated in either a 48-week intervention of intense Tai Chi training or a wellness education (WE) program. INTERVENTIONS: Eight Tai Chi forms emphasizing trunk rotation, weight shifting, coordination, and narrowing of lower-extremity stance were taught twice weekly. WE program participants met once a week and received lectures focused on health.Main outcome measures The COP was recorded during gait initiation both before and after the 48-week intervention by using a forceplate sampling at 300 Hz. The COP trajectory was divided into 3 periods (S1, S2, S3) by identifying 2 landmark events. Displacement and average velocity of the COP trace in the anteroposterior (x) and mediolateral (y) directions, as well as smoothness, were calculated. RESULTS: Tai Chi training increased the posterior displacement of the COP during S1 and improved the smoothness of the COP during S2. CONCLUSIONS: Tai Chi improved the mechanism by which forward momentum is generated and improved coordination during gait initiation, suggesting improvements in postural control. 相似文献
993.
Alan J. Robertson Natalie B. Tan Amanda B. Spurdle Alejandro Metke-Jimenez Clair Sullivan Nicola Waddell 《Genetics in medicine》2022,24(4):798-810
Re-analyzing genomic information from a patient suspected of having an underlying genetic condition can improve the diagnostic yield of sequencing tests, potentially providing significant benefits to the patient and to the health care system. Although a significant number of studies have shown the clinical potential of re-analysis, less work has been performed to characterize the mechanisms responsible for driving the increases in diagnostic yield.Complexities surrounding re-analysis have also emerged. The terminology itself represents a challenge because “re-analysis” can refer to a range of different concepts. Other challenges include the increased workload that re-analysis demands of curators, adequate reimbursement pathways for clinical and diagnostic services, and the development of systems to handle large volumes of data. Re-analysis also raises ethical implications for patients and families, most notably when re-classification of a variant alters diagnosis, treatment, and prognosis.This review highlights the possibilities and complexities associated with the re-analysis of existing clinical genomic data. We propose a terminology that builds on the foundation presented in a recent statement from the American College of Medical Genetics and Genomics and describes each re-analysis process. We identify mechanisms for increasing diagnostic yield and provide perspectives on the range of challenges that must be addressed by health care systems and individual patients. 相似文献
994.
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: ten.tsacmoc@cvSxRcnO; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: ten.retrahc@ruofddaw.
Regimen name: ADOrigin of name: AD is an acronym for the names of the 2 medications in the regimen: doxorubicin (Adriamycin) and dacarbazine. 相似文献
995.
The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and investigational, used to treat malignant diseases. Questions or suggestions for topics should be addressed to Dominic A. Solimando, Jr, President, Oncology Pharmacy Services, Inc., 4201 Wilson Blvd #110-545, Arlington, VA 22203, e-mail: ten.tsacmoc@cvSxRcnO; or J. Aubrey Waddell, Professor, University of Tennessee College of Pharmacy; Oncology Pharmacist, Pharmacy Department, Blount Memorial Hospital, 907 E. Lamar Alexander Parkway, Maryville, TN 37804, e-mail: ten.retrahc@ruofddaw.
Name: GefitinibSynonyms: Iressa, ZD1839 相似文献
996.
997.
McManama G; Lindon JN; Kloczewiak M; Smith MA; Ware JA; Hawiger J; Merrill EW; Salzman EW 《Blood》1986,68(2):363-371
There is evidence that platelet interactions with artificial surfaces are mediated by plasma proteins, especially fibrinogen, adsorbed on the surfaces. Multiple site interactions between fibrinogen molecules adsorbed in high concentration and receptors in the unactivated platelet may be sufficient for platelet adhesion and subsequent activation. To examine this hypothesis, we prepared soluble polymers of fibrinogen. Polymers produced by interaction of fibrinogen with Fab'2 fragments of antibodies against fibrinogen's E (central) domain (Fg- Fab'2(E] induced, in gel-filtered platelets, aggregation and serotonin release, which were blocked by monoclonal antibodies against the GPIIb/IIIa complex, by Fab fragments against the D domain, and by metabolic inhibitors; aggregation was attenuated but not abolished by enzymatic removal of ADP (with CP/CPK) or by blockage of ADP binding sites (with FSBA), and when secretion was inhibited by aspirin. Fg- Fab'2(E) also induced a dose-dependent elevation in cytoplasmic Ca2+ (measured by Aequorin luminescence) which was attenuated by CP/CPK and by FSBA, and was eliminated by metabolic inhibitors and by anti- IIb/IIIa antibody. Fibrinogen complexes crosslinked with dimethylsuberimidate or Factor XIII neither aggregated gel-filtered platelets nor inhibited platelet aggregation by ADP and fibrinogen, probably because of inaccessibility of lysine residues in the D (terminal) domain of fibrinogen, which are thought to be required for platelet binding. Thus, soluble complexes of fibrinogen having multiple available platelet receptor recognition sites activate gel-filtered platelets and may provide a useful model for platelet-surface interactions mediated by adsorbed fibrinogen. 相似文献
998.
Thrombin is a physiological agonist that promotes platelet aggregation and secretion. In this study we observed that thrombin can also inhibit a function of platelets related to primary hemostasis. Platelet stimulation by thrombin decreased the binding of von Willebrand factor (vWF) to glycoprotein (GP) Ib and decreased ristocetin-induced agglutination, in vitro reactions that correlate with initial platelet adhesion to the vessel wall. Binding of the monoclonal antibody API to GP Ib was also decreased. Cytoskeletal participation in the change of GP Ib was suggested because pretreatment of platelets with cytochalasin to prevent actin filament formation prevented the thrombin-induced decreases in vWF binding. API binding, and ristocetin-induced agglutination. Measurement of GP Ib in detergent extracts by electroimmunoassay demonstrated no loss after thrombin stimulation. Electroimmunoassay also demonstrated that the API epitope of GP Ib on intact thrombin-treated platelets was accessible for complete digestion by chymotrypsin. Therefore GP Ib was neither released from the platelet surface nor internalized by thrombin treatment. A previously recognized effect of thrombin is its induction of receptor sites on platelet surface GP IIb-IIIa for contact-promoting proteins, including vWF that are involved in the platelet spreading and aggregation that follow adhesion. Therefore the action on GP Ib may combine with the effect on GP IIb-IIIa to shift platelet reactivity from GP Ib-vWF-mediated initial contact with the vessel wall to GP IIb-IIIa-mediated spreading and aggregation. 相似文献
999.
Evidence for a novel binding protein to urokinase-type plasminogen activator in platelet membranes 总被引:3,自引:2,他引:3
Endogenous urokinase-type plasminogen activator (u-PA) has been identified in platelet membrane, and platelets have been shown to take up exogenous high molecular weight u-PA from the ambient medium. In this report, the mechanism of the association of u-PA with platelets was investigated using recombinant, single chain u-PA. When gel filtered human platelets were incubated with radiolabeled u-PA, the u- PA was found to specifically and saturably bind to the resting platelets in a dose-dependent manner. Unlabeled u-PA and the amino terminal fragment of u-PA inhibited 125I-u-PA binding to platelets with a mean IC50 of 65 and 58 nmol/L, respectively. A single saturable binding site in intact resting platelets was found with a mean kd of 43 +/- 25 nmol/L and 2263 +/- 809 sites per platelet. In contrast to resting platelets, 125I-u-PA did not bind to thrombin-induced platelets. Western blotting studies, using a monoclonal or a polyclonal antibody specific for the u-PA cell-surface receptor (u- PAR), failed to show evidence of u-PAR in resting platelets, whereas, u-PAR was found at approximately 54 and approximately 48 kD on U937 monocytes, which served as a positive control. Ligand blotting of platelet membrane and of U937 cell proteins with 125I-u-PA revealed a u-PA binding protein of approximately 70 kD in the platelets and one of approximately 54 kD in the U937 cells. Complexion of u-PA with a platelet membrane protein was also shown by gel filtration of a mixture of u-PA and platelet membrane proteins. A u-PA complex was further shown by enzyme-linked immunosorbent assay when microtiter plates were coated with platelet membrane proteins, and this complex formation was shown to be dose-dependent and saturable with an apparent kd of 17 nmol/L. It was concluded that platelet membrane contains a specific, high affinity u-PA-binding protein that is distinct from u-PAR. 相似文献
1000.
Societal change through an increase in knowledge and accessibility of education as well as a push for autonomy has contributed to a shift in the balance of power from clinician to patient (especially in the last 20 years). This drive for personal autonomy has seen a shift from medical paternalism, a consequence of ignorance, to personal autonomy, a continuously evolving by‐product of 17th century liberalism as expressed and facilitated by access of information. Consequently, patient‐centred care has become the new standard for health care involving a two‐way communication process of shared information and informed decision‐making. At its centre is the patient's right to accept or decline treatment recommended by a clinician, be it detrimental or beneficial. Clinicians must recognize and appreciate this shift to patient‐centred care and its legal ramifications. 相似文献